Researchers at University of California, San Diego School of Medicine have identified a control mechanism for an area of the brain that processes sensory and emotive information that humans experience as “disappointment.”
Thermo Fisher Scientific and the UC San Diego Office of Research Affairs have established the Duane Roth Innovation Grant, which provides scientific investigators at UC San Diego with a $50,000 annual funding opportunity for sponsored research that supports proof-of-concept and technology-applications studies.
A trip to the Guatemalan jungle usually nets a few souvenirs: Photographs of Maya ruins, bragging rights about encounters with venomous snakes, perhaps a bug bite or two.
Researchers at the University of California, San Diego School of Medicine have launched a phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for patients with chronic lymphocytic leukemia (CLL), the most common form of blood cancer in adults.
Imagine being able to switch out the batteries in electric cars just like you switch out batteries in a photo camera or flashlight. A team of engineers at the University of California, San Diego, are trying to accomplish just that, in partnership with a local San Diego engineering company.
During cancer development, tumor cells decorate their surfaces with sugar compounds called glycans that are different from those found on normal, healthy cells. Researchers at the University of California, San Diego School of Medicine report that sialic acids at the tips of these cancer cell glycans are capable of engaging with immune system cells and changing the latter’s response to the tumor – for good and bad.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
